Omeros Corporation
NASDAQ:OMERBiotechnology
+$0.43 today
- Market cap
- $1.08B
- Beta
- 2.53
- P/E (TTM)
- 8.4
- EPS (TTM)
- $1.20
Volume 2.53M
Average 1.55M
OMER Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Omeros CorporationNASDAQ: OMER
Common Stock · Q1 FY2026 · quarter ended Mar 2026
Common stock rises 24.1% from a year ago
Common stock stood at $720K at the end of Q1 FY2026, up 24.1% from a year earlier and up 0.6% from the prior quarter. Over 3 fiscal years it compounded at +4.5% a year.
Context
- Common stock amounted to 0.3% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Common stock increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether common stock keeps rising in the next quarterly balance sheet after a +24.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2025
- 716K USD
- Year-over-year change
- +23.4%
- 4-year CAGR
- +3.4%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 716K | +23.4% |
| FY2024 | 2024-12-31 | 580K | -5.1% |
| FY2023 | 2023-12-31 | 611K | -2.7% |
| FY2022 | 2022-12-31 | 628K | +0.3% |
| FY2021 | 2021-12-31 | 626K | — |
Common Stock vs competitors
How OMER compares with its peers on the latest reported figures
- OMER's Mar 2026 common stock of $720K is the 5th highest of the 11 companies compared; the peer median is $332.5K.
- Its year-over-year change of +24.1% is the 2nd highest of 11, against a peer median of +2.5%.
- Common stock amounts to 0.3% of total assets for OMER, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $2.17B | +21.0% | +20.6% | 234.7% | |
| Jun 2026 | $2.14B | +22.7% | +46.5% | 576.9% | |
| Mar 2026 | $3.15M | +0.4% | +8.2% | 7.7% | |
| Jun 2026 | $744K | +4.2% | +6.1% | 0.1% | |
| Mar 2026 | $720K | +24.1% | +4.5% | 0.3% | |
| Mar 2026 | $636K | +0.8% | +0.9% | 0.3% | |
| Mar 2026 | $29K | -3.3% | -1.2% | 0.0% | |
| Mar 2026 | $8K | +14.3% | +11.9% | 0.0% | |
| Mar 2026 | $6K | +0.0% | +6.3% | 0.0% | |
| Jun 2026 | $3K | +200.0% | -52.8% | 0.0% | |
| Mar 2026 | $0 | -100.0% | +3.0% | 0.0% | |
| Peer median (excluding OMER) | $332.5K | +2.5% | +6.2% | 0.1% | |
Competitors are the stored peer set for OMER. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 100.81M | 11.01M | 7.11M | 3.4M | 9.66M |
| Short-term Investments | 56.46M | 183.91M | 164.74M | 86.73M | 162.14M |
| Net Receivables | 82.47M | 242.02M | 6.72M | 36.82M | 36.27M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 67K | 6.3M | 30.75M | 7.17M | 7.6M |
| Total Current Assets | 247.96M | 443.24M | 217.9M | 134.12M | 215.67M |
| Property, Plant & Equipment (Net) | 30.01M | 23.25M | 20.58M | 17.64M | 12.48M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 141.31M | 124.48M | 139.79M | 125.32M | 97.49M |
| Total Non-current Assets | 171.31M | 147.73M | 160.37M | 142.96M | 109.97M |
| Total Assets | 419.27M | 590.97M | 378.27M | 277.08M | 325.63M |
| Account Payables | 13.4M | 5.99M | 7.71M | 5.91M | 4.76M |
| Short-term Debt | 0 | 94.38M | 8.58M | 21M | 17.06M |
| Tax Payables | 338K | 4.87M | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 2.47M |
| Other Current Liabilities | 3.71M | 7.82M | 0 | 29.51M | 30.9M |
| Total Current Liabilities | 51.79M | 136.38M | 53.32M | 79.53M | 78.06M |
| Long-term Debt | 313.46M | 220.91M | 329.71M | 166.58M | 208.54M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.12M | 125.57M | 2.09M | 200.11M | 153.02M |
| Total Non-current Liabilities | 343.7M | 368.9M | 349.94M | 380.16M | 368.8M |
| Total Liabilities | 395.49M | 505.29M | 403.25M | 459.69M | 446.86M |
| Common Stock | 626K | 628K | 611K | 580K | 716K |
| Retained Earnings | (683.13M) | (635.72M) | (753.53M) | (910.35M) | (913.7M) |
| Accumulated OCI | 0 | 0 | (0) | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 23.78M | 85.68M | (24.98M) | (182.61M) | (121.23M) |
| Total Debt | 347.84M | 342.02M | 361.58M | 207.02M | 239.14M |
| Net Debt | 247.03M | 331.01M | 354.48M | 203.62M | 229.48M |
Omeros Corporation
NASDAQ:OMER
Intrinsic Alpha fair value
Locked
Current Price
$14.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.